Atlas Trials

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

Clinical trial NCT01244906 · COMPLETED

Trial details

NCT number
NCT01244906
Sponsor
Northside Hospital, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hematologic Neoplasms
Start date
2010-12-01
Primary completion
2014-04-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.